Arcus Biosciences, Inc.RCUSNYSE
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-269.00M
↓ 124% below average
Average (8y)
$-119.89M
Historical baseline
Range
High:$59.00M
Low:$-291.00M
CAGR
+41.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-269.00M | +7.6% |
| 2023 | $-291.00M | -12.8% |
| 2022 | $-258.00M | -537.3% |
| 2021 | $59.00M | +149.2% |
| 2020 | $-120.00M | -47.9% |
| 2019 | $-81.13M | -58.5% |
| 2018 | $-51.20M | -0.7% |
| 2017 | $-50.83M | -201.3% |
| 2016 | $-16.87M | - |